Abstract
Ovarian hyperstimulation syndrome (OHSS) is a major complication associated with assisted reproductive technologies (ART). The severe form is associated with both considerable morbidity and mortality (1). Despite the identification of various risk factors for the development of OHSS, the only way to prevent its occurrence is to withhold hCG administration and cancel the cycle (2). This approach is safe, but it is costly and undesired by patients seeking treatment for infertility. Conception after an IVF cycle is associated with increased risks for the occurrence and prolonged duration of OHSS as a result of secretion of hCG by the trophoblast (3).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
